Mark A. Kay, MD, PhD, is the Dennis Farrey Family Professor in the
Departments of Pediatrics and Genetics, and Head of the Division of
Human Gene Therapy in Pediatrics at the Stanford University School of
Medicine. Professor Kay received his MD-PhD at Case Western Reserve
University and completed a residency in pediatrics, fellowship in medical
genetics and inborn errors of metabolism, and post-doctoral research at Baylor College of Medicine. Dr.
Kay was an assistant/associate professor at the University of Washington in the Department of Medicine
from 1993-1998 before moving to Stanford. Dr. Kay’s group has published over 275 papers in leading
journals. Dr. Kay is most well-known for his contributions in the field of gene-based therapeutics and noncoding
RNA biology specifically related to microRNA biogenesis and tRNA derived small RNAs.
Dr. Kay is one of the founders of the American Society of Gene and Cell Therapy and served as the
President in 2005-2006 and received the society’s outstanding investigator award in 2013. In 2021, he
was elected to the National Academy of Inventors. He spends much of his spare time doing landscape
and nature photography.
Mark A. Kay, MD, PhD, is the Dennis Farrey Family Professor in the
Departments of Pediatrics and Genetics, and Head of the Division of
Human Gene Therapy in Pediatrics at the Stanford University School of
Medicine. Professor Kay received his MD-PhD at Case Western Reserve
University and completed a residency in pediatrics, fellowship in medical
genetics and inborn errors of metabolism, and post-doctoral research at Baylor College of Medicine. Dr.
Kay was an assistant/associate professor at the University of Washington in the Department of Medicine
from 1993-1998 before moving to Stanford. Dr. Kay’s group has published over 275 papers in leading
journals. Dr. Kay is most well-known for his contributions in the field of gene-based therapeutics and noncoding
RNA biology specifically related to microRNA biogenesis and tRNA derived small RNAs.
Dr. Kay is one of the founders of the American Society of Gene and Cell Therapy and served as the
President in 2005-2006 and received the society’s outstanding investigator award in 2013. In 2021, he
was elected to the National Academy of Inventors. He spends much of his spare time doing landscape
and nature photography.
Mark A. Kay, MD, PhD, is the Dennis Farrey Family Professor in the
Departments of Pediatrics and Genetics, and Head of the Division of
Human Gene Therapy in Pediatrics at the Stanford University School of
Medicine. Professor Kay received his MD-PhD at Case Western Reserve
University and completed a residency in pediatrics, fellowship in medical
genetics and inborn errors of metabolism, and post-doctoral research at Baylor College of Medicine. Dr.
Kay was an assistant/associate professor at the University of Washington in the Department of Medicine
from 1993-1998 before moving to Stanford. Dr. Kay’s group has published over 275 papers in leading
journals. Dr. Kay is most well-known for his contributions in the field of gene-based therapeutics and noncoding
RNA biology specifically related to microRNA biogenesis and tRNA derived small RNAs.
Dr. Kay is one of the founders of the American Society of Gene and Cell Therapy and served as the
President in 2005-2006 and received the society’s outstanding investigator award in 2013. In 2021, he
was elected to the National Academy of Inventors. He spends much of his spare time doing landscape
and nature photography.